Atopic dermatitis, which many people call eczema ... or topical hydrocortisone, can help relieve mild symptoms. Doctors may also prescribe topical medications to treat small areas.
Atopic dermatitis (AD) is a skin disease of chronic inflammation exacerbated by acute flares that commonly affects infants, children, and adults. Therapies generally include emollients ...
“Topical therapies remain a cornerstone for treating atopic dermatitis (AD) whether patients have mild, moderate or severe disease. But there remains an unmet need for safe, effective and ...
Patients with atopic dermatitis (N=813 ... the median time to first worsening (defined as vIGA-AD ≥2 [mild]) was 57 days (95% CI, 30-79). The most common adverse reactions reported with ...
Technoderma Medicines, Inc. ('the Company'), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...
The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately controlled with topical therapies in patients aged 12 years and older ...
Perspective from Raj Chovatiya, MD, PhD Patients who used dupilumab for atopic dermatitis had significantly ... with 1,857 patients with mild AD who used non-systemic therapy (average age at ...